blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1162194

EP1162194 - Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  31.01.2003
Database last updated on 18.11.2024
Most recent event   Tooltip31.01.2003Application deemed to be withdrawnpublished on 19.03.2003  [2003/12]
Applicant(s)For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2001/50]
Inventor(s)01 / Klingler, Otmar, Dr.
Leipziger Ring 363
63110 Rodgau / DE
02 / Schudok, Manfred, Dr.
Eberlestrasse 28
65817 Eppstein/Ts. / DE
03 / Nestler, Hans-Peter, Dr.
Sendelbacher Weg 46
65779 Kelkheim / DE
04 / Matter, Hans, Dr.
Feldbergring 37
63505 Langenselbold / DE
05 / Schreuder, Herman, Dr.
Jahnstrasse 22
65179 Hofheim-Lorsbach / DE
 [2001/50]
Application number, filing date00112116.906.06.2000
[2001/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1162194
Date:12.12.2001
Language:EN
[2001/50]
Search report(s)(Supplementary) European search report - dispatched on:EP14.11.2000
ClassificationIPC:C07C275/42, C07D211/96, A61K31/17, A61P7/00, C07D213/40, C07D319/18
[2001/50]
CPC:
C07D213/40 (EP,US); C07C275/42 (EP,KR,US); A61P43/00 (EP);
A61P7/00 (EP); A61P7/02 (EP); A61P9/00 (EP);
C07D211/96 (EP,US); C07D319/18 (EP,US); C07C2602/08 (EP,US);
C07C2602/10 (EP,US); C07C2603/18 (EP,US) (-)
Designated contracting statesDE [2002/36]
Former [2001/50]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Auf Faktor VIIa inhibitorisch wirkende (Thio)-Harnstoff Verbindungen, Verfahren zu deren Herstellung und deren Verwendung[2001/50]
English:Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use[2001/50]
French:Dérivés de (thio)-urée inhibiteurs du facteur VIIa, procédé de leur préparation et leur utilisation[2001/50]
Examination procedure13.06.2002Application deemed to be withdrawn, date of legal effect  [2003/12]
11.10.2002Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2003/12]
Fees paidPenalty fee
Penalty fee Rule 85b EPC 1973
22.07.2002M01   Not yet paid
Additional fee for renewal fee
30.06.200203   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9417041  (SEARLE & CO [US], et al) [A] 1 * example -; claim - *;
 [A]WO9422907  (CASSELLA FARBWERKE MAINKUR AG [DE], et al) [A] 1 * example -; claim - *;
 [DA]EP0987274  (HOECHST MARION ROUSSEL DE GMBH [DE]) [DA] 1* claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.